Volume 10, Number 11—November 2004
ICEID & ICWID 2004
International Conference on Women and Infectious Diseases (ICWID)
International Conference on Women and Infectious Diseases, Atlanta, Georgia, February 27–28, 2004
Highlight and copy the desired format.
|EID||McDonald M, Anker M, Deal C, Mawle A, O’Connor S, Slaughter L, et al. International Conference on Women and Infectious Diseases, Atlanta, Georgia, February 27–28, 2004. Emerg Infect Dis. 2004;10(11):1963-1964. https://dx.doi.org/10.3201/eid1011.040612|
|AMA||McDonald M, Anker M, Deal C, et al. International Conference on Women and Infectious Diseases, Atlanta, Georgia, February 27–28, 2004. Emerging Infectious Diseases. 2004;10(11):1963-1964. doi:10.3201/eid1011.040612.|
|APA||McDonald, M., Anker, M., Deal, C., Mawle, A., O’Connor, S., & Slaughter, L. (2004). International Conference on Women and Infectious Diseases, Atlanta, Georgia, February 27–28, 2004. Emerging Infectious Diseases, 10(11), 1963-1964. https://dx.doi.org/10.3201/eid1011.040612.|
On February 27–28, 2004, scientists, clinicians, researchers, women’s health advocates, educators, policymakers, and representatives from nongovernmental organizations and community-based organizations gathered in Atlanta for the first International Conference on Women and Infectious Diseases (ICWID): From Science to Action. The Office of Minority and Women’s Health of the National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), spearheaded the conference. It was cosponsored by the World Health Organization, the Pan American Health Organization, the Department of Health and Human Services (DHHS), and the American Society for Microbiology.
The broad ICWID steering committee included representatives from the DHHS Office on Women’s Health, the National Institutes of Health Office for Research on Women’s Health, the National Institute of Allergies and Infectious Diseases, the National Institute for Child Health and Human Development, the Fogarty Center, and the Office of Women’s Health of the Health Resources and Services Administration. Academic, community-based, and philanthropic organizations as well as numerous CDC entities were involved. The conference’s goal was to enhance prevention and control of infectious diseases among women worldwide. The conference’s 400 attendees from 25 countries (both industrialized and developing nations) and 30 U.S. states recognized the need for a forum to address the complex set of concerns and issues surrounding women and infectious diseases.
Julie Gerberding, director of CDC and administrator of the Agency for Toxic Substances and Disease Registry, opened the conference with an overview of the impact of infectious diseases on women. The address reminded listeners of the female face of infectious diseases: women may be biologically more susceptible to certain infections and suffer more severe complications. Other keynote speakers included Paul DeLay of the Joint United Nations Programme on HIV/AIDS, Carol Bellamy of the United Nations Children’s Fund, and Mirta Roses Periago of the Pan American Health Organization.
The theme of the conference was “From Science to Action.” In 35 sessions, attendees discussed the importance of the practical application of scientific knowledge in areas such as HIV, infectious causes of chronic diseases and other infectious disease–chronic disease relationships, gender roles in infectious disease transmission and prevention, sexual coercion and its effect on infectious diseases in women, sexually transmitted diseases, health disparities, healthcare workers and caregivers, immunization, effective community-based strategies, the role of cultural competence in women’s health, and more.
The Bill and Melinda Gates Foundation sponsored 26 ICWID scholarships, which allowed persons from nongovernmental organizations and community-based organizations from 10 countries and four continents to attend who otherwise would not have had the opportunity. These ICWID scholars will amplify the conference’s impact by taking the knowledge and insights gained back to their home countries and organizations.
The conference successfully illuminated the female face of infectious diseases. While celebrating successes in the prevention and control of prenatal and neonatal Group B Streptococcus infections and achievements in other arenas, participants emphasized the many challenges remaining for the future. With the continuation of such efforts, the newly spotlighted female face of infectious diseases can also be the face of hope and progress.Cite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Marian McDonald, National Center for Infectious Diseases, CDC, 1600 Clifton Road NE, Mailstop D62, Atlanta, Georgia, 30333, USA; fax: 404-371-5487
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: May 04, 2011
- Page last updated: May 04, 2011
- Page last reviewed: May 04, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)